FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1α pathway

Cell Metabolism

Volumn 13, Issue 6, 2011, Pages 729-738

  Potthoff, Matthew J ^a,b   Boney Montoya, Jamie ^b   Choi, Mihwa ^b   He, Tianteng ^b   Sunny, Nishanth E ^b   Satapati, Santhosh ^b   Suino Powell, Kelly ^c   Xu, H Eric ^c   Gerard, Robert D ^b   Finck, Brian N ^d   Burgess, Shawn C ^a,b   Mangelsdorf, David J ^a,b   Kliewer, Steven A ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c VAN ANDEL RESEARCH INSTITUTE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILE ACID; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15; FIBROBLAST GROWTH FACTOR 19; GLUCOSE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEEDING; GENE EXPRESSION; GENE INACTIVATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; INHIBITION KINETICS; INSULIN BLOOD LEVEL; LIVER METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; SIGNAL TRANSDUCTION; SMALL INTESTINE;

ANIMALS; CITRIC ACID CYCLE; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FATTY ACIDS; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENES, REPORTER; GLUCONEOGENESIS; GLUCOSE; LIVER; LUCIFERASES; MALE; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 79958066536     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2011.03.019     Document Type: Article

References (50)

1. Ahrén, B., and Havel, P.J. (1999). Leptin increases circulating glucose, insulin and glucagon via sympathetic neural activation in fasted mice. Int. J. Obes. Relat. Metab. Disord. 23, 660-665.
2. Ayala, J.E., Bracy, D.P., McGuinness, O.P., and Wasserman, D.H. (2006). Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55, 390-397. (Pubitemid 43343268)
3. Ayala, J.E., Samuel, V.T., Morton, G.J., Obici, S., Croniger, C.M., Shulman, G.I., Wasserman, D.H., and McGuinness, O.P.; NIH Mouse Metabolic Phenotyping Center Consortium. (2010). Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Dis Model Mech 3, 525-534.
4. Bhatnagar, S., Damron, H.A., and Hillgartner, F.B. (2009). Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis. J. Biol. Chem. 284, 10023-10033.
5. Bittinger, M.A., McWhinnie, E., Meltzer, J., Iourgenko, V., Latario, B., Liu, X., Chen, C.H., Song, C., Garza, D., and Labow, M. (2004). Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins. Curr. Biol. 14, 2156-2161.
6. Burgess, S.C., He, T., Yan, Z., Lindner, J., Sherry, A.D., Malloy, C.R., Browning, J.D., and Magnuson, M.A. (2007). Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver. Cell Metab. 5, 313-320. (Pubitemid 46477858)
7. Burgess, S.C., Leone, T.C., Wende, A.R., Croce, M.A., Chen, Z., Sherry, A.D., Malloy, C.R., and Finck, B.N. (2006). Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator- activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice. J. Biol. Chem. 281, 19000-19008.
8. Burgess, S.C., Weis, B., Jones, J.G., Smith, E., Merritt, M.E., Margolis, D., Dean Sherry, A., and Malloy, C.R. (2003). Noninvasive evaluation of liver metabolism by 2H and 13C NMR isotopomer analysis of human urine. Anal. Biochem. 312, 228-234.
9. Choi, M., Moschetta, A., Bookout, A.L., Peng, L., Umetani, M., Holmstrom, S.R., Suino-Powell, K., Xu, H.E., Richardson, J.A., Gerard, R.D., et al. (2006). Identification of a hormonal basis for gallbladder filling. Nat. Med. 12, 1253-1255.
10. Chrivia, J.C., Kwok, R.P., Lamb, N., Hagiwara, M., Montminy, M.R., and Goodman, R.H. (1993). Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365, 855-859. (Pubitemid 23341031)
11. DeFronzo, R.A., Tobin, J.D., and Andres, R. (1979). Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237, E214-E223.
12. Dentin, R., Liu, Y., Koo, S.H., Hedrick, S., Vargas, T., Heredia, J., Yates, J., 3rd, and Montminy, M. (2007). Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. Nature 449, 366-369. (Pubitemid 47443476)
13. Finck, B.N., and Kelly, D.P. (2006). PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116, 615-622.
14. Fu, L., John, L.M., Adams, S.H., Yu, X.X., Tomlinson, E., Renz, M., Williams, P.M., Soriano, R., Corpuz, R., Moffat, B., et al. (2004). Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology 145, 2594-2603. (Pubitemid 38686202)
15. Goetz, R., Beenken, A., Ibrahimi, O.A., Kalinina, J., Olsen, S.K., Eliseenkova, A.V., Xu, C., Neubert, T.A., Zhang, F., Linhardt, R.J., et al. (2007). Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members. Mol. Cell. Biol. 27, 3417-3428.
16. Goldman, P.S., Tran, V.K., and Goodman, R.H. (1997). The multifunctional role of the co-activator CBP in transcriptional regulation. Recent Prog. Horm. Res. 52, 103-119, discussion 119-120.
17. Gonzalez, G.A., and Montminy, M.R. (1989). Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59, 675-680. (Pubitemid 19282874)
18. Hagiwara, M., Alberts, A., Brindle, P., Meinkoth, J., Feramisco, J., Deng, T., Karin, M., Shenolikar, S., and Montminy, M. (1992). Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB. Cell 70, 105-113.
19. Handschin, C., and Spiegelman, B.M. (2006). Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr. Rev. 27, 728-735.
20. Herzig, S., Long, F., Jhala, U.S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001). CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature 413, 179-183. (Pubitemid 32867880)
21. Hogg, R.T., Garcia, J.A., and Gerard, R.D. (2010). Adenoviral targeting of gene expression to tumors. Cancer Gene Ther. 17, 375-386.
22. Holt, J.A., Luo, G., Billin, A.N., Bisi, J., McNeill, Y.Y., Kozarsky, K.F., Donahee, M., Wang, D.Y., Mansfield, T.A., Kliewer, S.A., et al. (2003). Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17, 1581-1591. (Pubitemid 36828786)
23. Huang, X., Yang, C., Luo, Y., Jin, C., Wang, F., and McKeehan, W.L. (2007). FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver. Diabetes 56, 2501-2510. (Pubitemid 47523257)
24. Inagaki, T., Choi, M., Moschetta, A., Peng, L., Cummins, C.L., McDonald, J.G., Luo, G., Jones, S.A., Goodwin, B., Richardson, J.A., et al. (2005). Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2, 217-225.
25. Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007). Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21. Cell Metab. 5, 415-425. (Pubitemid 46825496)
26. Kerr, T.A., Saeki, S., Schneider, M., Schaefer, K., Berdy, S., Redder, T., Shan, B., Russell, D.W., and Schwarz, M. (2002). Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev. Cell 2, 713-720. (Pubitemid 34650068)
27. Kir, S., Beddow, S.A., Samuel, V.T., Miller, P., Previs, S.F., Suino-Powell, K., Xu, H.E., Shulman, G.I., Kliewer, S.A., and Mangelsdorf, D.J. (2011). FGF15/19 is a postprandial, insulin-independent activator of protein and glycogen synthesis. Science 331, 1621-1624.
28. Koo, S.H., Flechner, L., Qi, L., Zhang, X., Screaton, R.A., Jeffries, S., Hedrick, S., Xu, W., Boussouar, F., Brindle, P., et al. (2005). The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 437, 1109-1111.
29. Kraegen, E.W., James, D.E., Bennett, S.P., and Chisholm, D.J. (1983). In vivo insulin sensitivity in the rat determined by euglycemic clamp. Am. J. Physiol. 245, E1-E7.
30. Kurosu, H., Choi, M., Ogawa, Y., Dickson, A.S., Goetz, R., Eliseenkova, A.V., Mohammadi, M., Rosenblatt, K.P., Kliewer, S.A., and Kuro-o, M. (2007). Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J. Biol. Chem. 282, 26687-26695.
31. Kwok, R.P., Lundblad, J.R., Chrivia, J.C., Richards, J.P., Bächinger, H.P., Brennan, R.G., Roberts, S.G., Green, M.R., and Goodman, R.H. (1994). Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370, 223-226. (Pubitemid 24236779)
32. Lehman, J.J., Barger, P.M., Kovacs, A., Saffitz, J.E., Medeiros, D.M., and Kelly, D.P. (2000). Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J. Clin. Invest. 106, 847-856.
33. Lin, B.C., Wang, M., Blackmore, C., and Desnoyers, L.R. (2007). Liver-specific activities of FGF19 require Klotho beta. J. Biol. Chem. 282, 27277-27284.
34. Lin, J., Wu, P.H., Tarr, P.T., Lindenberg, K.S., St-Pierre, J., Zhang, C.Y., Mootha, V.K., Jäger, S., Vianna, C.R., Reznick, R.M., et al. (2004). Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119, 121-135. (Pubitemid 39349325)
35. Lundåsen, T., Gälman, C., Angelin, B., and Rudling, M. (2006). Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. J. Intern. Med. 260, 530-536.
36. Mayr, B., and Montminy, M. (2001). Transcriptional regulation by the phosphorylation- dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2, 599-609.
37. Michael, L.F., Asahara, H., Shulman, A.I., Kraus, W.L., and Montminy, M. (2000). The phosphorylation status of a cyclic AMP-responsive activator is modulated via a chromatin-dependent mechanism. Mol. Cell. Biol. 20, 1596-1603.
38. Parker, J.C., Andrews, K.M., Allen, M.R., Stock, J.L., and McNeish, J.D. (2002). Glycemic control in mice with targeted disruption of the glucagon receptor gene. Biochem. Biophys. Res. Commun. 290, 839-843.
39. Puigserver, P., and Spiegelman, B.M. (2003). Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24, 78-90.
40. Reiche, M., Bachmann, A., Lössner, U., Blüher, M., Stumvoll, M., and Fasshauer, M. (2010). Fibroblast growth factor 19 serum levels: relation to renal function and metabolic parameters. Horm. Metab. Res. 42, 178-181.
41. Screaton, R.A., Conkright, M.D., Katoh, Y., Best, J.L., Canettieri, G., Jeffries, S., Guzman, E., Niessen, S., Yates, J.R., 3rd, Takemori, H., et al. (2004). The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 119, 61-74. (Pubitemid 39349320)
42. Stejskal, D., Karpísek, M., Hanulová, Z., and Stejskal, P. (2008). Fibroblast growth factor-19: development, analytical characterization and clinical evaluation of a new ELISA test. Scand. J. Clin. Lab. Invest. 68, 501-507.
43. Sunny, N.E., and Bequette, B.J. (2010). Gluconeogenesis differs in developing chick embryos derived from small compared with typical size broiler breeder eggs. J. Anim. Sci. 88, 912-921.
44. Tomlinson, E., Fu, L., John, L., Hultgren, B., Huang, X., Renz, M., Stephan, J.P., Tsai, S.P., Powell-Braxton, L., French, D., and Stewart, T.A. (2002). Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity. Endocrinology 143, 1741-1747. (Pubitemid 34415889)
45. Wadzinski, B.E., Wheat, W.H., Jaspers, S., Peruski, L.F., Jr., Lickteig, R.L., Johnson, G.L., and Klemm, D.J. (1993). Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol. Cell. Biol. 13, 2822-2834.
46. Walters, J.R., Tasleem, A.M., Omer, O.S., Brydon, W.G., Dew, T., and le Roux, C.W. (2009). A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin. Gastroenterol. Hepatol. 7, 1189-1194.
47. Wang, Z., Zhang, B., Wang, M., and Carr, B.I. (2003). Persistent ERK phosphorylation negatively regulates cAMP response element-binding protein (CREB) activity via recruitment of CREB-binding protein to pp90RSK. J. Biol. Chem. 278, 11138-11144.
48. Wright, T.J., Ladher, R., McWhirter, J., Murre, C., Schoenwolf, G.C., and Mansour, S.L. (2004). Mouse FGF15 is the ortholog of human and chick FGF19, but is not uniquely required for otic induction. Dev. Biol. 269, 264-275.
49. Wu, X., Ge, H., Gupte, J., Weiszmann, J., Shimamoto, G., Stevens, J., Hawkins, N., Lemon, B., Shen, W., Xu, J., et al. (2007). Co-receptor requirements for fibroblast growth factor-19 signaling. J. Biol. Chem. 282, 29069-29072.
50. Yu, C., Wang, F., Kan, M., Jin, C., Jones, R.B., Weinstein, M., Deng, C.X., and McKeehan, W.L. (2000). Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4. J. Biol. Chem. 275, 15482-15489.